← Back to headlines
Xenon Pharmaceuticals Discloses Nasdaq-Compliant Inducement Stock Grants
Neurology-focused biotech Xenon reported granting stock awards under Nasdaq Listing Rule 5635(c)(4) to attract and retain key executive talent.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
